As mentioned previously, lower expression of TFAP2Β is associated with a poor prognosis of neuroblastoma since patients whose tumour cells have lowered TFAP2Β showed poor treatment outcomes [33]. The gene discussed is TFAP2A; the disease is neoplasm.